Studies (like this one, published in the Journal of the American Medical Association ) show patients taking the drug consistently showed weight loss over a 6-month period, and there are other reports (such as this landmark study) that the medication might even help to delay ageing, reducing the risk of mortality from heart disease and other factors
Questions about long-term effects of GLP-1s on children remain largely unanswered
IL-33-responsive lineage- CD25 + CD44(hi) lymphoid cells mediate innate type 2 immunity and allergic inflammation in the lungs
Davies MJ, Aroda VR, Collins BS, Gabbay RA, Green J, Maruthur NM, Rosas SE, Del Prato S, Mathieu C, Mingrone G, Rossing P, Tankova T, Tsapas A, Buse JB